CME Group Inc. Profile Avatar - Palmy Investing

CME Group Inc.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultura…
Financial - Data & Stock Exchanges
US, Chicago [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -7.30 74.80 80.69
Graham Fair Price 3.24 63.63 61.63
PEG 70.66 4.53 2.66
Price/Book -0.85 2.81 2.83
Price/Cash Flow 18.06 87.26 73.91
Prices/Earnings -4.09 22.27 23.22
Price/Sales -2.60 51.19 52.56
Price/FCF 18.06 87.26 73.91
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 0.36 0.82 0.82
Operating Margin 7.54 0.64 0.60
ROA 3.22 < 0.005 < 0.005
ROE 0.03 0.03 3.37
ROIC 0.02 0.02 4.20
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.12 0.13 -12.07
Dividends QOQ < 0.005 4.82 1983751.47
EBIT QOQ 0.05 0.11 113.02
EPS QOQ 0.09 0.05 -43.80
FCF QOQ 0.22 -0.15 -34.05
Revenue QOQ 0.08 0.03 -55.49
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 78.19 38.00 -51.40
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.12 0.11 -2.73
Quick Ratio 0.05 0.02 -50.22
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 74.44 75.58 1.54
Cash 8.43 4.35 -48.40
Capex -0.06 -0.06 4.82
Free Cash Flow 2.85 2.43 -14.73
Revenue 4.01 4.14 3.36
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.02 1.01 -0.32
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1.02 1.90 86.49
Naive Interpretation Member
06 - Financial Health · Bad
End of CME's Analysis
CIK: 1156375 CUSIP: 12572Q105 ISIN: US12572Q1058 LEI: - UEI: -
Secondary Listings
CME has no secondary listings inside our databases.